ABSTRACT

Dear Reader,

Welcome to a comprehensive exploration of one of the most dynamic and promising frontiers of scientific inquiry and technological innovation: nanobiotechnology. The concepts of nanobiotechnology are relatively recent, originating from Richard Feynman’s idea of ‘There’s Plenty of Room at the Bottom’ in 1959. However, his concept did not gain serious attention until 1986, when Eric Drexler published “Engines of Creation,” which discussed approaches and visions for controlled manufacturing of products at the molecular scale. Nanobiotechnology is a more recent discipline that has emerged at the convergence of nanotechnology and biotechnology. It involves the modification and utilisation of nanoscale structures inside biological systems. It has significantly expanded the realm of possibilities, fundamentally transforming several sectors such as industry, healthcare and scientific investigation. According to an industry analysis, the worldwide nanobiotechnology market was valued at USD 32.18 billion in 2022 and is projected to reach USD 70.26 billion by 2029, with a compound annual growth rate (CAGR) of 11.8%. This multidisciplinary domain has revolutionised the healthcare industry by facilitating the precise administration of medications, individualised treatment approaches and cutting-edge diagnostic instruments. The promise extends beyond the field of health, providing solutions in agriculture to increase crop yields, improve disease resistance and optimise nutrient delivery